Pfizer’s Bleak 2024 Forecast Casts Shadow on Recovery Prospects Post-2023 Downturn
Introduction: Pfizer Inc. faces a challenging entry into the new year as…
Moderna Faces $7 Billion Value Decline After Pfizer’s Caution
The COVID-19 pandemic officially came to a close several months ago, allowing…
